- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
South Korean Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
5
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
A000640 | ₩115,200.00 | -6.0% | 18.3% | ₩720.1b | ₩155,000.00 | PE14.1x | S7.6% | 1.6% | ||
A234080 | ₩11,190.00 | -1.7% | -12.0% | ₩173.3b | n/a | PE6.5x | n/a | 4.5% | ||
A006620 | ₩4,815.00 | -8.3% | -12.9% | ₩131.5b | n/a | PE10.1x | n/a | 2.5% | ||
A009300 | ₩19,440.00 | -9.2% | 23.4% | ₩118.6b | n/a | PE4.8x | n/a | 3.9% | ||
A012790 | ₩6,530.00 | -9.4% | -10.7% | ₩74.3b | n/a | PE4.7x | n/a | 2.6% |
Page 1 of 1